IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMC 2527999)

Published in PLoS One on September 05, 2008

Authors

Shrimati Datta1, Nora E Sarvetnick

Author Affiliations

1: Department of Immunology, The Scripps Research Institute, La Jolla, California, United States of America.

Articles citing this

New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol (2009) 5.57

Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol (2009) 3.05

Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes (2009) 1.53

Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest (2010) 1.40

Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest (2015) 1.14

An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol (2010) 1.13

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood (2011) 1.12

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. Diabetes (2011) 1.11

Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus. Proc Natl Acad Sci U S A (2009) 1.09

Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum (2010) 1.04

Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity (2012) 0.98

Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice. J Clin Invest (2011) 0.98

Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity. Eur J Immunol (2011) 0.88

Mapping quantitative trait loci for T lymphocyte subpopulations in peripheral blood in swine. BMC Genet (2011) 0.87

Post-operative infection and sepsis in humans is associated with deficient gene expression of γc cytokines and their apoptosis mediators. Crit Care (2011) 0.82

Cytokines and type 1 diabetes: a numbers game. Diabetes (2011) 0.82

The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohort. Clin Exp Immunol (2013) 0.81

IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis. J Clin Invest (2015) 0.79

Aberrant ROCK activation promotes the development of type I diabetes in NOD mice. Cell Immunol (2010) 0.79

Premature CD4+ T cell aging and its contribution to lymphopenia-induced proliferation of memory cells in autoimmune-prone non-obese diabetic mice. PLoS One (2014) 0.77

Articles cited by this

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature (2007) 16.59

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol (2007) 16.21

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature (2007) 14.28

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91

Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity (2008) 9.61

A critical role for IL-21 in regulating immunoglobulin production. Science (2002) 7.09

A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity (2008) 6.41

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86

Maintaining the norm: T-cell homeostasis. Nat Rev Immunol (2002) 5.63

Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell (2004) 5.59

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med (2002) 5.09

Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 5.07

Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol (2002) 4.95

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med (2005) 4.60

Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell (1997) 4.18

Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol (2005) 3.82

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity (2002) 3.17

Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell (1997) 3.13

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol (2007) 2.99

Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol (2001) 2.69

IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J Immunol (2005) 2.44

Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med (2002) 2.28

Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature (1990) 2.20

Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum (2007) 2.10

Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol (2004) 2.07

Autoimmunity during lymphopenia: a two-hit model. Clin Immunol (2006) 2.01

Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98

IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol (2007) 1.92

IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol (2002) 1.89

T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. Int Immunol (2001) 1.82

B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol (1998) 1.81

Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood (2001) 1.74

Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc Natl Acad Sci U S A (2002) 1.69

Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol (2005) 1.69

The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry (2002) 1.68

IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol (2003) 1.67

Spontaneous formation of germinal centers in autoimmune mice. J Leukoc Biol (2001) 1.62

A causal link between lymphopenia and autoimmunity. Immunol Lett (2004) 1.61

Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest (1997) 1.58

Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J Immunol (2006) 1.51

Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol (2005) 1.48

Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ (2000) 1.40

Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol (2001) 1.39

Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol (2005) 1.37

Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem (2004) 1.37

T cell homeostasis and systemic autoimmunity. J Clin Invest (2001) 1.35

The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol (2005) 1.32

Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes (2000) 1.31

T-cell compartments of prediabetic NOD mice. Diabetes (2003) 1.27

IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J Immunol (2005) 1.19

Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol (2006) 1.16

Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol (2005) 1.13

IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes. J Immunol (2007) 1.09

IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J Leukoc Biol (2007) 1.07

Interleukin-21 signaling: functions in cancer and autoimmunity. Clin Cancer Res (2007) 1.03

IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells. Int Immunol (2007) 1.02

B cell depletion: a novel therapy for autoimmune diabetes? J Clin Invest (2007) 1.00

B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J Immunol (2004) 0.96

Lymphopenia and autoimmune diseases. Arthritis Res Ther (2004) 0.90

Overexpression of bcl-2 in T cells affects insulitis in the nonobese diabetic mouse. Scand J Immunol (2003) 0.86

Interleukin 21 enhances antibody-mediated tumor rejection. Cancer Res (2008) 0.86

Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway. J Immunol (1999) 0.83

Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-diagnosed IDDM patients. Diabetologia (1995) 0.81